Short-term efficacy of vedolizumab in patients with inflammatory bowel disease in real-life settings in Bosnia and Herzegovina. (2024). Biomolecules and Biomedicine, 24(5), 1400–1406. https://doi.org/10.17305/bb.2024.10433